Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP3 | P08254 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19361986 | 0.83 | CYP2C9 (0.41) | CYP2C9MEN1KMT2APSMB5ALDH1A1 | |
| SCHEMBL13122874 | 0.83 | CYP2C9 (0.41) | CYP2C9MEN1KMT2APSMB5ALDH1A1 | |
| SCHEMBL13857488 | 0.83 | CTSC (0.34) | ALDH1A1MMP1MMP2MMP3LMNA | |
| SCHEMBL14131182 | 0.83 | CYP2C9 (0.41) | CYP2C9MEN1KMT2APSMB5ALDH1A1 | |
| SCHEMBL13857486 | 0.83 | ALDH1A1 (0.41) | CYP2C9ALDH1A1MMP1MMP2MMP3 | |
| SCHEMBL18513200 | 0.82 | CYP2C9 (0.39) | CYP2C9MEN1KMT2APSMB5L3MBTL1 | |
| SCHEMBL19155933 | 0.82 | CYP2C9 (0.39) | CYP2C9MEN1KMT2APSMB5L3MBTL1 | |
| SCHEMBL20756194 | 0.82 | CYP2C9 (0.39) | CYP2C9MEN1KMT2APSMB5ALDH1A1 | |
| SCHEMBL19486079 | 0.80 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1MMP1MMP2 | |
| SCHEMBL12537158 | 0.80 | ALDH1A1 (0.47) | MEN1KMT2AALDH1A1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131306-A1 | CHEMICALLY MODIFIED CYCLIC PEPTIDES CONTAINING CELL ADHESION RECOGNITION (CAR) SEQUENCES AND USES THEREFOR | ADHEREX TECHNOLOGIES, INC. (CA) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131306-A1 | CHEMICALLY MODIFIED CYCLIC PEPTIDES CONTAINING CELL ADHESION RECOGNITION (CAR) SEQUENCES AND USES THEREFOR | VCAM1, EPCAM, ADGRF1 | CYP2C9 4634/4885MEN1 1652/4885KMT2A 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.